Previously, miR-34a has been regarded as a tumor suppressor through targeting MET [29–32], a RTK (receptor tyrosine kinase) playing a key role in promoting cell proliferation via transducing extracellular stimuli to intracellular signalling circuits [33, 34], through PI3K/AKT signaling [31]. The gene discussed is AKT1; the disease is neoplasm.